Top Stories
-
A study led by Columbia researchers found that a minimally invasive technique to repair the mitral valve improved two-year survival for certain heart failure patients.
-
A new study led by Columbia's Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
Topic
-
For women, even mild sleep problems can raise blood pressure, finds a new study.
Topic
-
Columbia bioengineers used an electromechanical "workout" program to turn human stem cells into adult-like heart tissue in just four weeks.
Topic
Latest News
- February 23, 2018
Among children with congenital heart disease, those from low-income neighborhoods have higher mortality than kids from high-income areas, even when treated at the same hospitals.
Topic
- February 14, 2018
Andrew Moran, MD, internist and hypertension expert, addresses questions about the new blood pressure treatment guidelines.
Topic
- November 30, 2017
The first human heart transplant took place 50 years ago in South Africa, but Columbia was among a handful of places that helped the field mature.
Topic
- October 13, 2017
The Vivian and Seymour Milstein Family Infant Cardiac Unit is a state-of-the-art, 17-bed unit staffed by a multidisciplinary team of specialists in neonatal cardiac intensive care.
Topic
- September 21, 2017
Macrophages can eat up to 70 dead cells a day, preventing atherosclerosis. A new CUMC study finds that mitochondria play a critical role in the process.
Topic
- September 11, 2017
Sitting around for one to two hours at a time without moving increases the risk of death, finds a new study.
Topic
-
Source:
New York TimesAugust 28, 2017 - August 23, 2017
Higher up-front costs for intensive blood pressure control are outweighed by long-term cardiac benefits, shows study.
Topic
- August 15, 2017
A new clinical trial will determine if the drug apixaban can prevent recurrent strokes in people with atrial cardiopathy.
- August 1, 2017
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
